Non-Digestible Carbohydrate and the Risk of Colorectal Neoplasia: A Systematic Review

References

• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. doi:10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer WHO. Colorectal Cancer. Cancer Fact Sheets. 2018. [accessed 2018 Dec 30]. http://gco.iarc.fr/today/fact-sheets-cancers.
   Google Scholar
• Ma H, Yu Y, Wang M, Li Z, Xu H, Tian C, Zhang J, Ye X, Li X. Correlation between microbes and colorectal cancer: tumor apoptosis is induced by sitosterols through promoting gut microbiota to produce short-chain fatty acids. Apoptosis. 2019;24(1–2):168–183. doi:10.1007/s10495-018-1500-9
   PubMed Web of Science ®Google Scholar
• Yusuf F, Adewiah S, Fatchiyah F. The level short chain fatty acids and HSP 70 in colorectal cancer and non-colorectal cancer. Acta Inform Med. 2018;26(2):160–163. doi:10.5455/aim.2018.26.160-163
   PubMedGoogle Scholar
• Casanova MR, Azevedo-Silva J, Rodrigues LR, Preto A. Colorectal cancer cells increase the production of short chain fatty acids by Propionibacterium freudenreichii impacting on cancer cells survival. Front Nutr. 2018;5:44. doi:10.3389/fnut.2018.00044
   PubMed Web of Science ®Google Scholar
• Mudgil D, Barak S. Composition, properties and health benefits of indigestible carbohydrate polymers as dietary fiber: a review. Int J Biol Macromol. 2013;61:1–6. doi:10.1016/j.ijbiomac.2013.06.044
   PubMed Web of Science ®Google Scholar
• Robertson MD. Dietary-resistant starch and glucose metabolism. Curr Opin Clin Nutr Metab Care. 2012;15(4):362–7. doi:10.1097/MCO.0b013e3283536931
   PubMed Web of Science ®Google Scholar
• Flamm G, Glinsmann W, Kritchevsky D, Prosky L, Roberfroid M. Inulin and oligofructose as dietary fiber: a review of the evidence. Crit Rev Food Sci Nutr. 2001;41(5):353–362. doi:10.1080/20014091091841
   PubMed Web of Science ®Google Scholar
• van der Beek CM, Canfora EE, Kip AM, Gorissen SHM, Olde Damink SWM, van Eijk HM, Holst JJ, Blaak EE, Dejong CHC, Lenaerts K, et al. The prebiotic inulin improves substrate metabolism and promotes short-chain fatty acid production in overweight to obese men. Metabolism. 2018;87:25–35. doi:10.1016/j.metabol.2018.06.009
   PubMed Web of Science ®Google Scholar
• O’Keefe SJ, Ou J, Aufreiter S, O’Connor D, Sharma S, Sepulveda J, Fukuwatari T, Shibata K, Mawhinney T. Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J Nutr. 2009;139:2044–2048. doi:10.3945/jn.109.104380
   PubMed Web of Science ®Google Scholar
• Hu Y, Le Leu RK, Christophersen CT, Somashekar R, Conlon MA, Meng XQ, Winter JM, Woodman RJ, McKinnon R, Young GP, et al. Manipulation of the gut microbiota using resistant starch is associated with protection against colitis-associated colorectal cancer in rats. Carcin. 2016;37(4):366–375. doi:10.1093/carcin/bgw019
   PubMed Web of Science ®Google Scholar
• Hijova E, Szabadosova V, Strojny L, Bomba A. Changes chemopreventive markers in colorectal cancer development after inulin supplementation. BLL. 2014;115:76–79. doi:10.4149/BLL_2014_016
   PubMed Web of Science ®Google Scholar
• Toden S, Lockett TJ, Topping DL, Scherer BL, Watson E-JL, Southwood JG, Clarke JM. Butyrylated starch affects colorectal cancer markers beneficially and dose-dependently in genotoxin-treated rats. Cancer Biol Ther. 2014;15(11):1515–1523. doi:10.4161/15384047.2014.955764
   PubMed Web of Science ®Google Scholar
• Malcomson FC, Willis ND, Mathers JC. Is resistant starch protective against colorectal cancer via modulation of the WNT signalling pathway? Proc Nutr Soc. 2015;74(3):282–291. doi:10.1017/S002966511500004X
   PubMed Web of Science ®Google Scholar
• Burn J, Bishop DT, Chapman PD, Elliott F, Bertario L, Dunlop MG, Eccles D, Ellis A, Evans DG, Fodde R. A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res (Phila). 2011;4(5):655–665. doi:10.1158/1940-6207.CAPR-11-0106
   PubMed Web of Science ®Google Scholar
• Burn J, Bishop DT, Mecklin J-P, Macrae F, Möslein G, Olschwang S, Bisgaard M-L, Ramesar R, Eccles D, Maher ER, et al. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med. 2008;359(24):2567–2578. doi:10.1056/NEJMoa0801297
   PubMed Web of Science ®Google Scholar
• Dronamraju SS, Coxhead JM, Kelly SB, Burn J, Mathers JC. Cell kinetics and gene expression changes in colorectal cancer patients given resistant starch: a randomised controlled trial. Gut. 2009;58(3):413–420. doi:10.1136/gut.2008.162933
   PubMed Web of Science ®Google Scholar
• Mathers JC, Movahedi M, Macrae F, Mecklin J-P, Moeslein G, Olschwang S, Eccles D, Evans G, Maher ER, Bertario L, et al. Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet Oncol. 2012;13(12):1242–1249. doi:10.1016/S1470-2045(12)70475-8
   PubMed Web of Science ®Google Scholar
• van Gorkom BAP, Karrenbeld A, van der Sluis T, Zwart N, van der Meer R, de Vries EGE, Kleibeuker JH. Calcium or resistant starch does not affect colonic epithelial cell proliferation throughout the colon in adenoma patients: a randomized controlled trial. Nutr Cancer. 2002;43(1):31–38. doi:10.1207/S15327914NC431_3
   PubMed Web of Science ®Google Scholar
• Grubben MJAL, Braak CCM, Essenberg M, Olthof M, Tangerman A, Katan MB, Nagengast FM. Effect of resistant starch on potential biomarkers for colonic cancer risk in patients with colonic adenomas: a controlled trial. Dig Dis Sci. 2001;46(4):750–756.
   PubMed Web of Science ®Google Scholar
• Le Leu RK, Winter JM, Christophersen CT, Young GP, Humphreys KJ, Hu Y, Gratz SW, Miller RB, Topping DL, Bird AR, et al. Butyrylated starch intake can prevent red meat-induced O6-methyl-2-deoxyguanosine adducts in human rectal tissue: a randomised clinical trial. Br J Nutr. 2015;114(2):220–230. doi:10.1017/S0007114515001750
   PubMed Web of Science ®Google Scholar
• Worthley DL, Le Leu RK, Whitehall VL, Conlon M, Christophersen C, Belobrajdic D, Mallitt K-A, Hu Y, Irahara N, Ogino S, et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr. 2009;90(3):578–586. doi:10.3945/ajcn.2009.28106
   PubMed Web of Science ®Google Scholar
• Humphreys KJ, Conlon MA, Young GP, Topping DL, Hu Y, Winter JM, Bird AR, Cobiac L, Kennedy NA, Michael MZ, et al. Dietary manipulation of oncogenic microRNA expression in human rectal mucosa: a randomized trial. Cancer Prev Res (Phila). 2014;7(8):786–795. doi:10.1158/1940-6207.CAPR-14-0053
   PubMed Web of Science ®Google Scholar
• Wacker M, Wanek P, Eder E, Hylla S, Gostner A, Scheppach W. Effect of enzyme-resistant starch on formation of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal and cell proliferation in the colonic mucosa of healthy volunteers. Cancer Epidemiol Biomarkers Prev. 2002;11(9):915–920.
   PubMed Web of Science ®Google Scholar
• Malcomson FC, Willis ND, McCallum I, Xie L, Ibero-Baraibar I, Leung WC, Kelly S, Bradburn DM, Belshaw NJ, Johnson IT, et al. Effects of supplementation with nondigestible carbohydrates on fecal calprotectin and on epigenetic regulation of SFRP1 expression in the large-bowel mucosa of healthy individuals. Am J Clin Nutr. 2017;105(2):400–410. doi:10.3945/ajcn.116.135657
   PubMed Web of Science ®Google Scholar
• Heijnen ML, van Amelsvoort JM, Deurenberg P, Beynen AC. Limited effect of consumption of uncooked (RS2) or retrograded (RS3) resistant starch on putative risk factors for colon cancer in healthy men. Am J Clin Nutr. 1998;67(2):322–331. doi:10.1093/ajcn/67.2.322
   PubMed Web of Science ®Google Scholar
• Malcomson FC, Willis ND, McCallum I, Xie L, Lagerwaard B, Kelly S, Bradburn DM, Belshaw NJ, Johnson IT, Mathers JC, et al. Non-digestible carbohydrates supplementation increases miR-32 expression in the healthy human colorectal epithelium: a randomized controlled trial. Mol Carcinog. 2017;56(9):2104–11. : doi:10.1002/mc.22666
   PubMed Web of Science ®Google Scholar
• Muir JG, Walker KZ, Kaimakamis MA, Cameron MA, Govers MJ, Lu ZX, Young GP, O’Dea K. Modulation of fecal markers relevant to colon cancer risk: a high-starch Chinese diet did not generate expected beneficial changes relative to a Western-type diet. Am J Clin Nutr. 1998;68(2):372–9. doi:10.1093/ajcn/68.2.372
   PubMed Web of Science ®Google Scholar
• van Munster IP, Tangerman A, Nagengast FM. Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation. Digest Dis Sci. 1994;39(4):834–42. doi:10.1007/BF02087431
   PubMed Web of Science ®Google Scholar
• Limburg PJ, Mahoney MR, Ziegler KLA, Sontag SJ, Schoen RE, Benya R, Lawson MJ, Weinberg DS, Stoffel E, Chiorean M. Cancer Prevention Network. Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention. Cancer Prev Res (Phila). 2011;4(2):259–269. doi:10.1158/1940-6207.CAPR-10-0215
   PubMed Web of Science ®Google Scholar
• Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'Riordan M, O'Sullivan GC, Pool-Zobel B, et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr. 2007;85(2):488–496. doi:10.1093/ajcn/85.2.488
   PubMed Web of Science ®Google Scholar
• Roller M, Clune Y, Collins K, Rechkemmer G, Watzl B. Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br J Nutr. 2007;97(4):676–684. doi:10.1017/S0007114507450292
   PubMed Web of Science ®Google Scholar
• Friederich P, Verschuur J, van Heumen BW, Roelofs HM, Berkhout M, et al. Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis. Int J Colorectal Dis. 2011;26:575–582. doi:10.1007/s00384-010-1127-y
   PubMed Web of Science ®Google Scholar
• Langlands SJ, Hopkins MJ, Coleman N, Cummings JH. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut. 2004;53(11):1610–6. doi:10.1136/gut.2003.037580
   PubMed Web of Science ®Google Scholar
• Humphreys KJ, Cobiac L, Le Leu RK, Van der Hoek MB, Michael MZ. Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster. Mol Carcinog. 2013;52(6):459–74. doi:10.1002/mc.21879
   PubMed Web of Science ®Google Scholar
• Spurling CC, Suhl JA, Boucher N, Nelson CE, Rosenberg DW, Giardina C. The short chain fatty acid butyrate induces promoter demethylation and reactivation of RARbeta2 in colon cancer cells. Nutr Cancer. 2008;60(5):692–702. doi:10.1080/01635580802008278
   PubMed Web of Science ®Google Scholar
• Encarnação JC, Abrantes AM, Pires AS, Botelho MF. Revisit dietary fiber on colorectal cancer: butyrate and its role on prevention and treatment. Cancer Metastasis Rev. 2015;34(3):465–78. doi:10.1007/s10555-015-9578-9
   PubMed Web of Science ®Google Scholar
• Saldanha SN, Kala R, Tollefsbol TO. Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate. Exp Cell Res. 2014;324(1):40–53. doi:10.1016/j.yexcr.2014.01.024
   PubMed Web of Science ®Google Scholar
• Clarke JM, Topping DL, Bird AR, Young GP, Cobiac L. Effects of high-amylose maize starch and butyrylated high-amylose maize starch on azoxymethane-induced intestinal cancer in rats. Carcinogenesis. 2008;29(11):2190–4. doi:10.1093/carcin/bgn192
   PubMed Web of Science ®Google Scholar
• Hald S, Schioldan AG, Moore ME, Dige A, Laerke HN, Agnholt J, Bach Knudsen KE, Hermansen K, Marco ML, Gregersen S, et al. Effects of arabinoxylan and resistant starch on intestinal microbiota and short-chain fatty acids in subjects with metabolic syndrome: a randomised crossover study. PLoS One. 2016;11(7):e0159223. doi:10.1371/journal.pone.0159223
   PubMed Web of Science ®Google Scholar
• Bauer-Marinovic M, Florian S, Müller-Schmehl K, Glatt H, Jacobasch G. Dietary resistant starch type 3 prevents tumor induction by 1,2-dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon. Carcinogenesis. 2006;27(9):1849–59. doi:10.1093/carcin/bgl025
   PubMed Web of Science ®Google Scholar
• Le Leu RK, Brown IL, Hu Y, Esterman A, Young GP. Suppression of azoxymethane-induced colon cancer development in rats by dietary resistant starch. Cancer Biol Ther. 2007;6(10):1621–6. doi:10.4161/cbt.6.10.4764
   PubMed Web of Science ®Google Scholar
• Luo J, Chen J, Deng Z-L, Luo X, Song W-X, Sharff KA, Tang N, Haydon RC, Luu HH, He T-C, et al. Wnt signaling and human diseases: what are the therapeutic implications?. Lab Invest. 2007;87(2):97–103. : doi:10.1038/labinvest.3700509
   PubMed Web of Science ®Google Scholar
• Cray NL. Effects of diets containing digestion-resistant starch on Wnt pathway control of proliferation and differentiation of the colorectal mucosa. Ames: Iowa State University, 2013. pp. 35–69.
   Google Scholar
• Bordonaro M, Lazarova DL, Sartorelli AC. The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors. Exp Cell Res. 2007;313(8):1652–66. doi:10.1016/j.yexcr.2007.02.008
   PubMed Web of Science ®Google Scholar
• Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000;16(4):168–74. doi:10.1016/S0168-9525(99)01971-X
   PubMed Web of Science ®Google Scholar
• Shin H, Kim JH, Lee YS, Lee YC. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling. Int J Oncol. 2012;40:1533–42. doi:10.3892/ijo.2012.1327
   PubMed Web of Science ®Google Scholar
• Berni Canani R, Di Costanzo M, Leone L. The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin Epigenetics. 2012;4(1):4. doi:10.1186/1868-7083-4-4
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–66. doi:10.1038/nrc1997
   PubMed Web of Science ®Google Scholar
• Clarke JM, Young GP, Topping DL, Bird AR, Cobiac L, Scherer BL, Winkler JG, Lockett TJ. Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated rats. Carcinogenesis. 2012;33(1):197–202. doi:10.1093/carcin/bgr254
   PubMed Web of Science ®Google Scholar
• Jacobasch G, Schmiedl D, Kruschewski M, Schmehl K. Dietary resistant starch and chronic inflammatory bowel diseases. Int J Colorectal Dis. 1999;14(4-5):201–11. doi:10.1007/s003840050212
   PubMed Web of Science ®Google Scholar
• Winter J, Young GP, Hu Y, Gratz SW, Conlon MA, Le Leu RK. Accumulation of promutagenic DNA adducts in the mouse distal colon after consumption of heme does not induce colonic neoplasms in the western diet model of spontaneous colorectal cancer. Mol Nutr Food Res. 2014;58(3):550–8. doi:10.1002/mnfr.201300430
   PubMed Web of Science ®Google Scholar
• Mentschel J, Claus R. Increased butyrate formation in the pig colon by feeding raw potato starch leads to a reduction of colonocyte apoptosis and a shift to the stem cell compartment. Metabolism. 2003;52(11):1400–5. doi:10.1016/S0026-0495(03)00318-4
   PubMed Web of Science ®Google Scholar
• IJssennagger N, Rijnierse A, de Wit N, Jonker-Termont D, Dekker J, Müller M, van der Meer R. Dietary haem stimulates epithelial cell turnover by downregulating feedback inhibitors of proliferation in murine colon. Gut. 2012;61(7):1041–9. doi:10.1136/gutjnl-2011-300239
   PubMed Web of Science ®Google Scholar